Results 151 to 160 of about 5,695,316 (423)
What you always wanted to know about genetic algorithms but were afraid to hear [PDF]
arXiv, 2000 In spite of their seemingly "obvious" virtues as a search strategy, genetic algorithms have ended up playing only a modest role as design tools in science and engineering. We review the reasons for this apparent failure, and we suggest a more relaxed view of their utility.
arxiv
Genetic engineering: Eukaryotic proteins retargetted among cell compartments [PDF]
, 1985 John Ellis
openalex +1 more source
Regulating Human Gene Therapy [PDF]
, 1985 Scientific developments have moved the public debate on genetic engineering to the issue of human gene therapy. Because so many important societal values must be weighed in deciding which, if any, of the first protocols for human gene therapy should be ...
Areen, Judith C.
core +1 more source
Molecular Oncology, EarlyView.This study simultaneously investigated circulating tumor cells (CTCs) and exosomes from small‐cell lung cancer (SCLC) patients. The elevated expression of JUNB and CXCR4 in CTCs was a poor prognostic factor for SCLC patients, whereas exosomal overexpression of these biomarkers revealed a high discrimination ability of patients from healthy individuals,
Dimitrios Papakonstantinou +13 more
wiley +1 more source
GeNet: A Multimodal LLM-Based Co-Pilot for Network Topology and Configuration [PDF]
arXivCommunication network engineering in enterprise environments is traditionally a complex, time-consuming, and error-prone manual process. Most research on network engineering automation has concentrated on configuration synthesis, often overlooking changes in the physical network topology.
arxiv
Molecular Oncology, EarlyView.Analysis of ESR1 mutations in plasma cell‐free DNA (cfDNA) is highly important for the selection of treatment in patients with breast cancer. Using multiplex‐ddPCR and identical blood draws, we investigated whether circulating tumor cells (CTCs) and cfDNA provide similar or complementary information for ESR1 mutations.
Stavroula Smilkou +11 more
wiley +1 more source
A new approach to planning in vitro and in vivo experiments for cardiovascular stents. (1) Fundamentals of design procedures [PDF]
, 2000 Copyright @ 2000 Pacini Editore SpAWhile the use of cardiovascular stents is internationally widespread re-stenosis remains a common problem. There are a number of different designs, and this project seeks for design improvements leading to a reduction ...
Atherton, MA, Collins, MW, Doorly, DJ
core
Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer
Molecular Oncology, EarlyView.mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia +17 more
wiley +1 more source
Genetic engineering and foot and mouth disease vaccines [PDF]
, 1981 J. B. Brooksby
openalex +1 more source